Cholangiocarcinoma Clinical Trials in Hangzhou, Zhejiang

12 recruitingHangzhou, Zhejiang, China

Showing 112 of 12 trials

Recruiting

Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia

Gastric CancerCholangiocarcinomaPancreatic Carcinoma+3 more
Zhejiang University1,200 enrolled2 locationsNCT07359586
Recruiting
Phase 2

Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement

Advanced CholangiocarcinomaFGFR2 FusionsGene Rearrangement
Taiho Oncology, Inc.120 enrolled65 locationsNCT05727176
Recruiting
Phase 2

Exploring the Safety and Efficacy of Sacituzumab Tirumotecan Combined With Pucotenlimab in the Treatment of Advanced Cholangiocarcinoma

Cholangiocarcinoma
Sir Run Run Shaw Hospital59 enrolled1 locationNCT07105852
Recruiting
Phase 2

Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer

Biliary Tract CancerCholangiocarcinomaGall Bladder Cancer+1 more
First Affiliated Hospital of Zhejiang University60 enrolled1 locationNCT07025174
Recruiting
Phase 1Phase 2

Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma

Advanced Intrahepatic Cholangiocarcinoma
Zhejiang University30 enrolled1 locationNCT06956716
Recruiting
Phase 2

GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence

Intrahepatic Cholangiocarcinoma
Zhejiang Cancer Hospital20 enrolled2 locationsNCT05557578
Recruiting
Phase 3

Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma

Advanced Cholangiocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University80 enrolled1 locationNCT05823311
Recruiting

Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma

Cholangiocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University300 enrolled1 locationNCT06718257
Recruiting
Phase 2

Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients with Advanced Cholangiocarcinoma

Advanced Cholangiocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled1 locationNCT05532059
Recruiting
Phase 2

Clinical Study of VG161 in Advanced Intrahepatic Cholangiocarcinoma

Advanced Intrahepatic Cholangiocarcinoma
CNBG-Virogin Biotech (Shanghai) Ltd.33 enrolled1 locationNCT06746480
Recruiting

Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis

Breast CancerLiver CancerColorectal, Cancer+10 more
Beijing Friendship Hospital2,700 enrolled4 locationsNCT06363123
Recruiting
Not Applicable

Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic Cholangiocarcinoma

Bile Duct CancerExtrahepatic Cholangiocarcinoma
First People's Hospital of Hangzhou70 enrolled1 locationNCT05519319